Literature DB >> 19157631

Measuring appropriate use of antibiotics in pyelonephritis in Belgian hospitals.

Cécile Camberlin1, Dirk Ramaekers.   

Abstract

Inappropriate use of antibiotics can induce antibiotic resistance, treatment failure, increased costs and even mortality. We developed a methodology for measuring guideline compliance of hospital antibiotic prescriptions in community-acquired acute pyelonephritis in Belgium. The claims and clinical data of all Belgian hospitalizations for community-acquired acute pyelonephritis were extracted from a nationwide administrative database. In a clinically homogeneous subset of patients, the percentage of patients who received a guideline-compliant prescription was calculated according to prescription guidelines disseminated in Belgium. In the group of non-pregnant adult female patients, 31% of the prescriptions were not in strict compliance with the guideline. Interhospital variability ranged from 0% to 100% compliance. We conclude that administrative databases can be used to analyze antibiotic prescription behavior in hospitals for homogeneous and clinically relevant patient groups. The interhospital variability observed in Belgian hospitals indicate that there is a clear room for improvement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157631     DOI: 10.1016/j.cmpb.2008.12.002

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  2 in total

1.  Descriptive Epidemiology of Acute Pyelonephritis in Korea, 2010-2014: Population-based Study.

Authors:  Bongyoung Kim; Rangmi Myung; Jieun Kim; Myoung-Jae Lee; Hyunjoo Pai
Journal:  J Korean Med Sci       Date:  2018-11-12       Impact factor: 2.153

2.  Differences in antibiotic usage patterns for acute pyelonephritis according to hospital type and region in the Republic of Korea: A population-based study.

Authors:  Rangmi Myung; Jun Hee Han; Bongyoung Kim
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.